INSIGHTS ON DRUG DEVELOPMENT

• Simplify Process Scale-Up With An Innovative Single-Use Bioreactor

  Consistent cell growth and protein yields from 5 L to 5,000 L show how a unified bioreactor design can simplify scale-up, reduce risk, and accelerate upstream process development in bioproduction.

• Scale Your Viral Vector Production With A Streamlined Bioreactor System

  Scale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.

• Assessing The Success Of CRISPR Gene Therapies Using ddPCR Technology

  Achieve high-fidelity results in gene therapy research. Discover how absolute quantification overcomes traditional limitations to provide the precision needed for validating CRISPR edits.

• The QX700: Advanced Digital PCR System

  Advanced digital PCR workflows provide precise, standard-free quantification. Maximize insights from small samples with seven-target multiplexing and automated steps to ensure high-throughput accuracy.

• Optimize Your RNA-LNP Delivery With Ionizable Lipids

  4/3/2025

  Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.

• Data-Driven Strategies To De-Risk OSD Development

  6/17/2026

  Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.

• Tablet Manufacturing Technologies For Solid Drug Formulation

  4/2/2025

  Compressed tablets are common oral solid dosages that contain the API and various excipients. Learn about the critical steps in selecting manufacturing methods and excipients to achieve the desired therapeutic effects and stability.

• Analyzing Biological Drug Effects In 3D

  10/24/2025

  Explore how 3D tumor microtissues paired with fluorescence-based assays offer scalable, high-sensitivity drug testing to deliver stronger signals and reproducible results compared to monolayer cultures.

• Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging

  5/6/2026

  High‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.